AR and posterior cortical atrophy: For example, researchers developed a DNA vaccine targeting the AR ligand‐binding domain (pTVG‐AR) that induces a TH1‐type immune response to eliminate PCa cells.[142] In the subsequent trial (NCT02411786),[143] patients with pTVG‐AR showed continued IFN‐γ immune responses.